Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster presentation 1

559 - Impact of genetic variation in microRNA binding site on susceptibility to colorectal cancer


19 Dec 2015


Poster presentation 1


Byung Woog Kang


Annals of Oncology (2015) 26 (suppl_9): 42-70. 10.1093/annonc/mdv523


B.W. Kang1, J.G. Kim1, Y.S. Chae2, S.J. Lee1, S. Yoon1, G.S. Choi3

Author affiliations

  • 1 Oncology/hematology, Kyungpook National University Medical Center, 702-210 - Daegu/KR
  • 2 Hematology/oncology, Kyungpook National University Hospital, 700-721 - Daegu/KR
  • 3 Surgery, Kyungpook National University Medical Center, 702-210 - Daegu/KR


Abstract 559


The present study analyzed SNPs located at putative miRNA-binding sites of the 3'-UTR in various genes and investigated their impact on the susceptibility to CRC.


Ninety-two SNPs were selected using an in Silico analysis of 3'-UTR SNPs in a SNP database and calculating their miRNA bind efficiency using several miRNA databases and the HapMap database. Two independent study sets were used: 380 healthy control subjects and 371 colorectal adenocarcinoma patients for the discovery set, and 521 healthy control subjects and 524 colorectal adenocarcinoma patients for the replication set. The SNP genotyping was performed using a Sequenom MassARRAY. Plus, a luciferase assay was used to investigate whether miR-370 modulated DOK3 gene expression when rs2279398G > A was included in the DOK3 3'-UTR region.


For the discovery set, 16 out of 92 SNPs were significantly associated with the risk of CRC in at least one of the genetic models. Meanwhile, the replication set showed that among these 16 SNPs, DOK3 rs2279398G > A was significantly associated with the risk of CRC in a recessive model (adjusted odds ratio (OR) = 0.65, 95% confidence interval (CI) = 0.44-0.97, P = 0.03). In a combined analysis, DOK3 rs2279398G > A was associated with a significantly decreased risk of CRC in a codominant and recessive model (adjusted OR = 0.84, 95% CI = 0.73-0.96, P = 0.012, adjusted OR = 0.65, CI = 0.49-0.88, P = 0.004, respectively). A significantly lower Renilla activity was also observed with the rs2279398 AA construct when compared with the rs2279398 GG construct (P < 0.001).


DOK3 rs2279398G > A may affect the expression of DOK3 by altering the miRNA binding efficiency at the miRNA-binding sites of the 3'-UTR in DOK3, thereby impacting CRC tumorigenesis.

Clinical trial identification


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings